Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer Genetics|September 17, 2021
Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platformDarren King, Charles E Foucar, Vincent Ma, et al.
Leukemia & Lymphoma|November 7, 2023
Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-upChristy J Khouderchah, Lydia L Benitez, Bernard L Marini, et al.
Leukemia & Lymphoma|July 15, 2021
Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphomaGrace T Baek, Noah J Mathis, Anthony J Perissinotti, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 3, 2025
Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agentsTaylor Gabbard, Bernard L Marini, Kamran M Mirza, et al.
Annals of Hematology|December 31, 2017
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAGGianni B Scappaticci, Bernard L Marini, Victoria R Nachar, et al.
Leukemia Research|March 1, 2021
Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blastsJustin H Reid, Anthony J Perissinotti, Lydia L Benitez, et al.
Annals of Hematology|January 23, 2019
The leukemia strikes back: a review of pathogenesis and treatment of secondary AMLEdna Cheung, Anthony J Perissinotti, Dale L Bixby, et al.
Cancer Treatment Reviews|August 14, 2023
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panelAnthony J Perissinotti, Michael R Bishop, Joseph Bubalo, et al.
European Journal of Haematology|November 6, 2023
Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of MichiganCharles E Foucar, Daniel H Foley, Jessica Aldous, et al.
Leukemia & Lymphoma|December 27, 2019
Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomasTaylor M Weis, Bernard L Marini, Victoria R Nachar, et al.
Pageof 7